Nasopharyngeal carcinoma (NPC) is a squamous-cell carcinoma that arises in the epithelial lining of the nasopharynx [1]. This neoplasm has a notable ethnic and geographic distribution, being of high prevalence in southern China but rare in other parts of the world [2]. Familial clustering of NPC has been observed in diverse populations [3]. Elevated levels of circulating free Epstein-Barr virus (EBV) DNA and EBV-related antibodies in sera, as well as EBV DNA in tumor cells, have been consistently detected in individuals with NPC [4,5]. These studies have revealed that the risk factors of NPC are both environmental and genetic. How the risk factors interact, and the genes that are involved in the development of NPC, are not well understood [6].
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Genetic factors and GWAS analysis
Early linkage analysis on Chinese sib-pairs with NPC suggested an association of particular human leukocyte antigen (HLA) haplotypes on chromosome 6p21 with susceptibility to NPC [7] . Supported by affected sib-pair haplotype sharing analysis and association studies on HLA regions, an NPC susceptibility locus was proposed, which was closely linked to the major histocompatibility complex but distinct from the HLA genes [8] . In addition, we and others have reported additional susceptibility loci on chromosomes 3p21 [9,10], 4p15.1-q12 [11] , and 5p13 [12] through linkage studies on NPC families from southern China. Many other candidate genes have also been implicated in NPC susceptibility [1320].
Genome-wide association studies (GWAS) using state-of-the-art research tools are a rapid and cost-effective way to analyze the genetic differences between people with a specific illness and healthy individuals [21] . The purpose of these studies is to identify the genetic risk factors for the development or progression of disease. Recently, three groups have conducted GWAS for NPC in Taiwan, China [22] , Malaysia [23] , and Guangdong and Guangxi in Southern China [24] , respectively. Consistent with previous reports, multiple independent associations within the HLA region, including HLA-A, HLA-F, HLA-B/C, and HLA-DQ/DR, were revealed. The investigators hypothesized that some HLA antigens have reduced efficiency in activating the host immune response to EBV infection, which plays a critical role in the pathogenesis of NPC. These studies also suggested that certain genetic variations in GABBR1 [22] ,
ITGA9
[23], TNFRSF19, MDS1-EVI1, and CDKN2A [24] may influence susceptibility to NPC. Surprisingly, most of the single nucleotide polymorphisms associated with NPC are not in protein-coding regions of DNA. Instead, they are usually in the large intergenic regions, or in the introns that are edited out of the DNA sequence when mRNAs are processed. These are presumably motifs that control other genes or are in linkage disequilibrium with functional genomic regions, but in general, their function is not known.
Transcriptomics
Transcriptomics, also referred to as gene expression profiling, examines the variety, structure, function, and regulation of all transcripts in a given cell at a given time. It can illuminate the molecular mechanisms and regulatory networks involved in the various stages of NPC. Though suppression subtractive hybridization [25] has been successful in isolating tissue-specific genes in nasopharyngeal epithelial tissue [26, 27] and candidate molecular markers of NPC [28], high-throughput techniques based on DNA microarrays are the most effective and convenient means to profile gene expression in NPC [29] . RNA-Seq is a recently developed approach to transcriptome profiling that uses deepsequencing technology; it is expected to provide useful information in NPC transcriptomics [30] .
NPC tissue is heterogeneous and consists of cancer cells, numerous infiltrating inflammatory cells, and non-neoplastic nasopharyngeal epithelium and stroma. Therefore, obtaining specific groups of cells from tissue slides by microdissection is very important. Because the samples microdissected from NPC tissue are usually very small, RNA amplification is necessary for the subsequent experiments [31] . We [3235] and others [3638] have performed genome-wide transcriptome analysis by probing cDNA or oligonucleotide microarrays with fluorescently-labeled amplified RNA derived from laser-capture microdissected cells obtained from normal nasopharyngeal epithelium and areas of metaplasia-dysplasia and carcinoma from NPC. This approach enabled the identification of genes differentially expressed in each cell population, as well as numerous genes whose expression patterns helped to explain the aggressive clinical nature of this tumor type. For example, genes involved in the cell cycle [35] and those controlling invasive-metastatic potential were highly expressed in tumor cells. In contrast, genes under-expressed in these tumors included those involved in apoptosis, cell structure, and putative tumor suppressors [32] . The gene expression patterns also suggested alterations in the Wnt/beta-catenin and transforming growth factor beta pathways in NPC [33] . These results were further verified by a custom high-throughput tissue array platform [39, 40] . Thus, expression profiling has indicated that the aberrant expression of growth, survival, and invasion-promoting genes may contribute to the molecular pathogenesis of NPC. One analysis method, known as Gene Set Enrichment Analysis, identifies co-regulated gene networks rather than individual genes that are up-or down-regulated in different cell populations [35, 41] . This approach may help to identify useful markers of disease progression and novel potential therapeutic targets for NPC [42] .
Proteomics
The transcriptome can be seen as a precursor for the proteome: that is, the entire set of proteins expressed by a transcriptome [43, 44] . However, the levels of mRNA are not directly proportional to the levels of the proteins they encode. The number of protein molecules synthesized using a given template mRNA is highly dependent on the translation-initiation features of the mRNA sequence. There are two major strategies used for protein separation in proteomics: gel-dependent and gel-independent strategies [45] . In the gel-dependent strategy, two-dimensional gel electrophoresis (2-DE) coupled with mass spectrometry (MS) is commonly used to screen the "differential display" of proteins to compare their levels. In the gel-independent strategy, liquid chromatography (LC) or multi-dimensional LC replaces 2-DE to separate proteins or peptides, and these proteins or peptides are identified by MS [46, 47] . LC-tandem MS (MS/MS) allows more definitive identification and quantitative determination of protein compounds [48, 49] ; this method complements the gel-dependent strategy. Surface-enhanced laser desorption/ionization time-of-flight MS (SELDI-TOF-MS) or SELDI ProteinChip technology [50] is a hybrid technology of retentate chromatography and matrix-assisted laser desorption/ionization (MALDI) TOF-MS, which allows protein capture, purification, and analysis on the ProteinChip surface and generates peaks in a mass spectrum (SELDI peaks) with unique mass-to-charge ratios detected by TOF-MS. Besides these "traditional" proteomics technologies, there has been much effort to develop new proteomics technologies to provide systematic proteomic data [51] , including quantitative expression profiles [5255], activity profiles, modification profiles, and interaction maps [5661]. More advanced fragmentation methods in MS, such as electron capture dissociation and electron transfer dissociation [62] , and chip-based proteomics strategies [63] , including forward or reverse protein microarrays, have been used in proteomic modification profiles [64] .
To understand NPC globally at the protein level, Li et al. An early diagnosis is one of the promises that proteomics hopes to fulfill. Recently, Cheng et al. analyzed the proteomes of NPC and normal nasopharyngeal epithelial tissues, and identified three potential biomarkers: stathmin, 14-3-3 sigma, and annexin I. Significant up-regulation of stathmin, and down-regulation of 14-3-3 sigma and annexin I, were observed in NPC and were significantly correlated with poor histologic differentiation, advanced clinical stage, recurrence, and poor prognosis [66, 67] . Radiotherapy is the primary treatment for NPC, but radioresistance remains a serious obstacle to successful treatment in many cases. By comparing the protein profiles of radioresistant and radiosensitive cell lines, Feng et al. found that the down-regulation of 14-3-3 sigma and maspin and the up-regulation of GRP78 and Mn-SOD were significantly correlated with NPC radioresistance. Therefore, 14-3-3 sigma, maspin, GRP78, and Mn-SOD are potential biomarkers for predicting NPC response to radiotherapy [68] . Using proteomics, we analyzed the profile of serum peptides, also referred to as peptidome (the low molecular weight proteome) of NPC patients compared with normal control cases, and constructed diagnosis patterns for the early diagnosis of NPC [69] . Proteomics has also been used to explore the biological functions of novel NPC-associated genes in cellular signaling networks [70] . NGX6 [71, 72] , NAG7 [73, 74] , and BRD7 [75, 76] are novel genes cloned in our lab. To investigate their function, 2-DE was used to compare the protein expression profiles of NPC and control cell lines transfected with these genes. After staining and image analysis, differentially expressed protein spots were isolated and subjected to MS. We identified several proteins of interest that are regulated by these genes.
Epigenetics
Epigenetics is an important component of functional genomics. It can be defined as the study of the interplay between the environment and genetics, and the study of heritable changes that are not strictly dependent on the DNA sequence [77] . Epigenetic alterations, including DNA methylation [78, 79] , histone modification [80] , chromatin remodeling [81, 82] , and non-coding RNA regulation [83] , resulting in the loss of tumor suppressor gene function, are frequently involved in tumor development and progression [84] . Aberrant methylation of CpG islands on tumor suppressor genes such as NME1 [85] , RASSF1A [86, 87] , UCHL1 [88] , ANXA1 [89] , and SFN [90] is a characteristic epigenetic feature of NPC genomic DNA. MicroRNAs (miRNAs) constitute a family of small non-coding RNA molecules that are 22-25 nucleotides long [9193] . Recent studies have demonstrated that miRNAs are intimately involved in the processes leading to NPC, such as gene regulation [94] , cell growth [95] , mitosis, tumor angiogenesis, invasion, and migration [96] . Exploring the relationship between miRNAs and the development of NPC will further the understanding of this cancer and provide new avenues for diagnosis and treatment [97] .
EBV and nanobacteria
The human nasopharyngeal epithelium is directly exposed to all the toxic dusts and pathogens of the outside environment. Chronic inflammation of the nasopharynx caused by these pathogens is one important cause of NPC. EBV is an oncogenic human herpesvirus [98] that contains a DNA genome of 172 kb. Latent membrane protein 1 (LMP1) is considered a viral oncogene [99] , since it shows transforming activity in various cell types in vitro. Expression of LMP1 in immortalized nasopharyngeal epithelial cells induces an array of genes involved in growth stimulation, enhanced survival, and increased invasive potential [100102] . The large EBV genome restricted previous studies to the study of a single oncogene. For the first time, we set up cell and animal models that allowed stable infection by the entire EBV genome [103] . This method provided the basis for whole-genome level investigations into the mechanism by which EBV contributes to NPC development [104] . We found that infection with the whole genome of EBV significantly promoted the growth and malignancy of epithelial cells [105] and activated NF-κB and MAPK signaling [106] .
We first demonstrated the existence of nanobacteria (NB) by electron microscopy of a biopsy from an NPC patient, and then isolated NB for culture to verify our hypothesis [107] . NB are a new class of Gram-negative bacteria with sizes ranging from 50 to 400 nm diameter. We observed the co-existence of NB and EBV in NPC tissue, which resulted in the swelling of infected cells and inflammation in the relevant tissues. Electron micrographs of NPC tissue and in vitro culture studies showed that NB recruit calcium salts, and promote integration of the EBV genome into nasopharyngeal epithelial cells. EBV-infected cells then express oncogenes such as LMP1 to promote their transformation into malignant tumor cells [108] . This is considered a direct early-stage pathway of NPC caused by NB and EBV. Besides promoting EBV infection, we showed that NB could secrete lipopolysaccharide, which stimulates the expression and release of cytokines such as TNF-α, the expression of cytokine receptors such as CD14, TLR4 [109] , and MD2, and the activation of p65, ERK1/2, and JNK1/2 that leads to NF-κB and MAPK signaling [110] . Over-activation of these two pathways leads to cell proliferation and finally tumorigenesis. These data provided evidence that NB could induce NPC by mediating inflammation or the inflammation-cancer chain in the early phase of NPC. Taken together, we identified NB as a causative pathogen of NPC. From an etiological perspective, we showed that NB promoted infection by EBV and the inflammatory response of epithelial cells that induces NPC. The roles played by NB account for the major molecular events in the early phase of NPC.
Important genes in NPC carcinogenesis
SPLUNC1 is important in the early phase of NPC because it encodes a protein that inhibits NB and EBV activity. SPLUNC1 controls signaling through a gene-environmentmiRNA-target gene transduction pathway consisting of SPLUNC1-EBV/NB-miR141-PTEN, mediating the interaction between genes and the environment. The SPLUNC1 gene was isolated by suppression subtractive hybridization from a cDNA pool of adult nasopharyngeal epithelial cells and NPC cells [25, 26] , and it is uniquely expressed in nasopharyngeal epithelium [111] . Repeated gene-chip examination has demonstrated significant down-regulation of this gene in NPC [28, 32, 34] . We found that SPLUNC1 encodes a secreted protein that covers the surface of epithelial cells of the respiratory tracts. This protein could bind to the lipopolysaccharide of NB through its bactericidal/permeabilityincreasing domain to inhibit the growth of NB and other bacteria [107] . It could also inhibit tumorigenesis caused by EBV by promoting the lysis of EBV-infected cells, inhibiting the expression of oncogenes such as LMP1, promoting the expression of the gp350 viral protein that would enhance the immune response, and compromising the integrity of EBV [108] . These features suggest that SPLUNC1 is a part of the innate immune system [112] , important in the defense against NB and EBV as well as being involved in the subsequent chronic inflammation they cause. In the case of EBV infection, the expression of LMP1 inhibited the expression of SPLUNC1 in nasopharyngeal epithelial cells, leading to loss of innate immunity. In addition, SPLUNC1 may regulate miR141 [94] and the downstream PTEN-AKT signaling [113, 114] , and also the MAPK, NF-κB [115] , Bcl-2/Bax [116] , and toll-like receptor [109,117119] inflammatory response pathways [120] , and ultimately the control of the cell cycle [121] . This pathway regulates the apoptotic cellular defense mechanism against cancer.
BRD7 is a tumor suppressor transcription factor that regulates the cell cycle in the progressive phase of NPC. The transcription factor and target genes, MYC-BRD7-BRD2/ BRD3, play important roles in NPC cell proliferation and the control of apoptosis. BRD7 was cloned by cDNA representational difference analysis combined with library screening [122, 123] . BRD7 was found to inhibit the progress NPC cells from G 1 to S phase, to induce apoptosis, slow cell growth, and reverse the malignancy of NPC cells [75] . Hybridization of a cell cycle-specific chip and a tumor-associated gene chip, and kinase activity analysis, showed that BRD7 could inhibit NPC development through regulation of the RAS/MEK/ERK, Rb/E2F [124, 125] , and WNT signaling pathways [126] during the progressive phase of NPC. BRD7 belongs to the bromodomain family and binds to acetylated histone H3, regulating the phosphorylation of the 10th lysine to transmit the transcription signal. BRD7 localizes in the nucleus, and contains a nuclear localization signal (amino acids 65-96) [127] . BRD2 and BRD3 belong to the same bromodomain family [128] , and interact with BRD7 to inhibit the cell cycle and trigger apoptosis. BRD7 enhances the transcription of BRD2 and BRD3, suggesting that these two factors are downstream of BRD7 in anti-NPC signaling. Upstream of BRD7 signaling, the 5′ end of BRD7 (-293 to -186 bp) is a functional promoter containing binding sites for c-Myc and E2F6. c-Myc negatively regulates promoter activity and mRNA expression of BRD7 [129] . Moreover, the promoter region of BRD7 is GC-rich and is regulated by methylation [130] ; aberrant methylation is an important mechanism of BRD7 dysfunction in NPC.
NAG7 is another important regulator in the progressive phase of NPC, playing important roles in NPC cell proliferation and metastasis. NAG7 was cloned from chromosome 3p25.3-26.3, the minimal common region of allelic loss among NPC patients [131] . NAG7 was found to be down-regulated in or absent from NPC biopsy tissues and cell lines. It functions by inhibiting cell cycle progression and promoting apoptosis [132] . We introduced gene chip [133] and proteomic [73] techniques when we studied this gene. We constructed differential gene and protein expression profiles induced by overexpression NAG7 in NPC cells, and found that our identified differentially expressed genes mainly participated in transcriptional regulation, cell growth, the cell cycle, cell metabolism, and apoptosis signaling transduction pathways. We also found that GAS1 was up-regulated at both the mRNA and protein levels upon NAG7 overexpression, suggesting that NAG7 signaling might be mediated by GAS1. Our methodology combined the study of a single gene with both genomic and proteomic approaches, and we obtained the same results with both methods, providing an important basis for functional genomic studies of NPC. In further studies, we found that NAG7 could inhibit estrogen receptor alpha (ER-α) [134] expression in NPC cells, activate the H-ras/p-c-raf, JNK/AP-1, and AKT/p70s6k signaling pathways, and regulate genes such as CAV1, MMP1 and EZR, thus promoting the metastatic ability of NPC cells [135] .
NOR1 encodes a mitochondria-reactive tumor suppressor protein (MiTS-NOR1) [136] with an antioxidant function, which was able to inhibit the Warburg effect in NPC cells to inhibit tumor growth [137, 138] . Intracellular reactive oxygen species can cause damage to cellular proteins, DNA, and organelles, leading to genomic instability and cancer. Therefore antioxidation is an important cellular defense mechanism against cancer-inducing stimuli. MiTS-NOR1 is almost specifically expressed in the nasopharynx and tracheal epithelial cells [139] , and was found to be regulated by the oxidative stress-related transcription factors heat shock transcription factor 1 (HSF1) and nuclear respiratory factor 1 (NRF1). We proved that oxidative stress, induced by treatment with hydrogen peroxide, could increase the expression of MiTS-NOR1 in normal nasopharyngeal epithelial cells through activation of HSF1 and NRF1, preventing further cellular damage [140] . Further studies with immunofluorescence, immuno-electron microscopy, and Western blotting confirmed that MiTS-NOR1 interacts with the ATP5O/OSCP subunit of mitochondrial ATP synthase to inhibit the expression of mitochondrial PDHK1 [141] . This inhibition would increase the efficiency of aerobic metabolism, increase the cellular ATP level, lower glucose consumption, and reduce the generation of lactic acid and glycolysis, all of which could reverse the Warburg effect in cancer cells. Additionally, MiTS-NOR1 could regulate the ratio of Bax/Bcl-2 in mitochondria, leading to the release of cytochrome C, activating the mitochondrial apoptosis pathway through caspase 9 and 3, and therefore leading to the apoptosis of NPC cells.
The AP1-miR214-LTF regulatory axis is critical in NPC invasion and metastatic processes. Based on genetic linkage analysis of 18 human families at high-risk of NPC, we identified a 13.6-cM region on chromosome 3p21 that was tightly linked to the development of NPC [9,10]. We designed a gene chip containing all 288 genes in this region, and found that LTF was significantly down-regulated in NPC tissues; this was further confirmed using a custom tissue chip containing 976 NPC tissue samples [142] . The down-regulation of LTF was tightly associated with metastasis of NPC. Yi et al. [143] reported that heterozygous loss of the LTF gene was found in 25% of NPC patients. Besides this, one or more point mutations, single nucleotide polymorphisms, or methylation of the promoter region of LTF could contribute to NPC susceptibility. The lactoferrin protein encoded by LTF is widely distributed in mammalian tissues, milk, and other exocrine fluids such as tears, nasal secretions, and saliva, and it has antibacterial, antiviral, anti-inflammatory, and immune-regulatory functions as well as inhibition of tumor growth. We found that LTF could inhibit NPC cell growth, arrest the cell cycle in stage G 0 -G 1 , down-regulate JNK2 and ERK in MAPK signaling, down-regulate cyclin D1 and phos-RB, and up-regulate p21 and p27. These findings suggest that LTF inhibits NPC growth by regulating both the cell cycle and the MAPK signaling pathway [142] . We also showed that LTF could inhibit the invasion and metastasis of NPC. An NPC cell line with re-expression of LTF showed reduced metastatic ability in vitro, and reduced tumorigenesis and lung metastasis in vivo when transplanted into nude mice [142] . The underlying mechanism is the inhibition of PDPK1 by LTF; PDPK1 controls the phosphorylation of AKT. LTF could also inhibit the membrane localization of AKT. PDPK1/AKT signaling plays important roles in tumor cell proliferation and metastasis. In a large-scale clinical investigation, we found that LTF expression levels were negatively correlated with NPC metastasis, suggesting its potential as a prognostic marker [142] . We also demonstrated that LTF is a target gene of miR-214. The examination of normal nasopharyngeal tissue, nasopharyngeal primary tumor tissue, and NPC metastases showed that the expression level of LTF was negatively correlated with that of miR-214, and miR-214 expression levels were significantly higher in metastatic NPC than in primary NPC [142] . The promoter region of miR-214 contains a binding site for the transcription factor AP-1, which is highly active in NPC tissue. AP-1 promoted the expression of miR-214 and inhibited LTF expression, forming the AP1-miR214-LTF axis that underlies LTF down-regulation in NPC tissues [142] . The inhibition of miR-214 expression significantly decreased the metastasis and invasion of NPC, suggesting a role for this axis in NPC development. Besides these findings, LTF inhibited the surface protein gp350 of EBV, and competed for the CD21 receptor on lymphocytes to inhibit the entry of EBV into the cells. LTF also inhibited the activity of intracellular EBV. We further found that LTF inhibited the migration of B cells, blocking B cell-mediated viral transmission from epithelial cells. The roles played by LTF in preventing viral infection as well as in innate immunity are therefore critical in NPC development [142] .
NGX6 is another important protein in the anti-metastasis of NPC. NGX6 is a cellular surface glycoprotein containing an epidermal growth factor-like structural domain [144150], which was found to be down-regulated in or absent from NPC biopsy tissues and cell lines [151154] . NGX6 has two transcripts of different sizes; NGX6a, the longer transcript, is involved in NPC development and is negatively correlated with lymph metastasis [155, 156] . Restoring the expression of NGX6 significantly decreased the invasion and metastasis of NPC, improved the gap junction communication between cells, and reversed the malignancy of NPC cells [157] . Further studies showed that NGX6 regulated K-RAS [158] , MEK1, and JUN expression, inhibited the phosphorylation of EGFR and MAPK kinase activity, up-regulated the expression of adhesion molecules such as nm23 and cadherin α2, and interacted with the cytoskeletal protein ezrin [151, 159] . NGX6 inhibited the cell cycle and cell proliferation through the EGFR/ras/MEK/MAPK pathway [144, 160, 161] , and interacted with adhesion molecules to regulate the adhesion and migration of cells, altering the invasion and metastasis of the tumor [162] .
Besides the above-mentioned genes, we and others have identified other genes involved in NPC carcinogenesis, including BMI1 [163, 164] , CCND1 [165] [174] , RKIP [175] , and ABCB1 [176] . Some potential drugs [177] , for example, an N-sugar-substituted thalidomide analog [178] and 3,5-hydroxy-6,7,3′,4′-tetramethoxyflavone [179] have been evaluated.
Gene regulation networks in NPC
We have reconstructed the activity spectrum of transcription factors and miRNAs in the different phases of NPC. We demonstrated dynamic changes in the activities of 26 transcription factors: for instance, the activities of AP2, ATF1, and ATF2 positively correlated with NPC severity [180, 181] . Whereas the miRNAs miR34b/c, miR18a/b, and miR99a/b functioned as inhibitors of NPC, miR141 and miR200C were oncogenes for NPC [94] . Our combined analyses of the activity spectra and proteomics data showed that, although there was considerable inter-phase variability, the primary signaling pathways were MAPK, WNT, AKT, and NF-κB. These findings led to a "transcription factor→ critical genes→miRNAs→target genes" regulatory network and a multistep model of NPC development, which comprises "environmental factors → SPLUC1 → BRD7/NAG7/ NOR1→LTF/NAX6→tumor invasion and metastasis". We proposed the hypothesis that NPC is a disease of dysfunction in signal transduction and network regulation, and that the NPC susceptibility genes direct these multiple steps in sequence [182] . We believe that these susceptibility genes inform the progression of both the restrictive and susceptible checkpoints of NPC development, with one or more susceptibility genes being involved at each checkpoint. Several susceptible stages in this progression would constitute a chain in which all the susceptibility genes formed a highly interactive susceptibility gene group.
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